You have 9 free searches left this month | for more free features.

City

San Antonio (2)

Bloomington (1)

Boston (1)

Dallas (1)

Fairfax (1)

Houston (1)

Nashville (1)

New York (1)

Scottsdale (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Monte Rosa Therapeutics, Inc (1)

Orum Therapeutics USA, Inc. (1)

Collaborator

Intervention

oral mrt-2359 (1)

orm-5029 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

GSPT1

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

Recruiting

NSCLC
+6 more

Oral MRT-2359

Scottsdale, Arizona
+7 more

Dec 20, 2022

HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in San Antonio, Fairfax (ORM-5029)

Not yet recruiting

HER2-positive Breast Cancer
+3 more

ORM-5029

San Antonio, Texas
+1 more

Aug 22, 2022